Artificial Blood: Finding the Formula for Approval
This article was originally published in Start Up
Executive Summary
Despite decades of effort and more than $1 billion dollars invested in commercial blood substitute R&D, no products are approved for use in the US. Can next-generation companies succeed where so many others have failed?